Document:

Exhibit
10.1

MARVELL TECHNOLOGY GROUP
LTD. 

AMENDED AND RESTATED 1995 STOCK OPTION PLAN

REFORMATION OF STOCK OPTION
AGREEMENT

This Reformation of Stock Option Agreement is entered
into by and between Sehat Sutardja (the “Optionee”) and Marvell Technology Group
Ltd., a Bermuda corporation (the “Company”), effective as set forth below.

Recitals

WHEREAS, the Company previously issued to the Optionee
an option (the “Option”) to acquire 1,500,000 shares (which have since split on
a 1 for 4 basis)  of common stock of the
Company at an exercise price of $9.125 per share (post-split) pursuant to a
stock option agreement dated effective December 26, 2003 (the “Agreement”)
under the Company’s Amended and Restated 1995 Stock Option Plan (the “Plan”);

WHEREAS, the parties subsequently reformed the
Agreement to reflect an exercise price per share of $10.91 (post-split);

WHEREAS, the number of shares subject to the Option
exceeded the annual per grant limit under the Plan by 500,000 pre-split
(2,000,000 post-split) shares;

WHEREAS, the Option has been exercised with respect to
2,200,788 (post-split) shares before 2006 and 799,212 (post-split) shares in
2006; and

WHEREAS, the parties hereby further reform the
Agreement to correspond to the share limit set forth in the Plan.

Agreement

NOW, THEREFORE, the parties hereto, intending to be
legally bound, hereby agree as follows:

A.            The terms of the Option and
Agreement are hereby reformed, effective May 5, 2007, to reflect that the
number of shares subject to the portion of the Option which has not been
exercised is 1,000,000 (post-split) shares.  The 2,000,000 shares cancelled shall be in
inverse order of vesting such that unvested shares which are the last to vest
shall be the first to be cancelled.

B.            The terms of the Agreement not
specifically reformed hereby remain in full force and effect.

C.            All defined terms used herein but
not otherwise defined shall have the meaning assigned to such terms in the
Agreement.

D.            This Reformation of Stock Option
Agreement shall be governed by the laws of the State of California.

E.             The Optionee has had an opportunity
to consult with the Optionee’s personal advisors with regard to this Reformation
of Stock Option Agreement, and is not relying on the Company or its agents for tax,
legal or investment advice.  The Optionee
agrees that the Company shall not be liable for any costs, loss or damage (other
than taxes) that the Optionee may incur by entering into this Reformation of
Stock Option Agreement; it being understood that the Optionee will not pursue a
claim (i) with respect to such costs, loss or damage (other than taxes), or (ii)
with respect to costs incurred in connection with the negotiation and
preparation of this Reformation of Stock Option Agreement; provided, however,
that nothing herein shall affect any rights of the Optionee to indemnification
pursuant to the Company’s bye-laws or any other agreements or instruments of or
with the Company or any of its subsidiaries. 
Without limiting the generality of the foregoing, the Company agrees to
indemnify Optionee for any taxes incurred by entering into this Reformation of
Stock Option Agreement.

The parties hereto have duly executed this Reformation
of Stock Option Agreement on the dates set forth below.

	
  MARVELL TECHNOLOGY GROUP
  LTD.

  
	
   

  
	
  By:

  	
  /s/ Paul R. Gray

  	
   

  
	
   

  
	
  Name:

  	
  Paul R. Gray

  	
   

  
	
   

  
	
  Title:

  	
  On behalf of
  Implementation Committee

  	
   

  
	
   

  
	
  Date:

  	
  May 6, 2007

  	
   

  
	
   

  
	
   

  	
  /s/ Sehat
  Sutardja

  	
   

  
	
   

  	
  Signature of
  Optionee

  
	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
  Sehat Sutardja

  
	
   

  	
   

  
	
   

  	
  Date:

  	
  5/6/2007Exhibit
10.2

MARVELL TECHNOLOGY GROUP
LTD. 

AMENDED AND RESTATED 1995 STOCK OPTION PLAN

AMENDMENT OF STOCK OPTION
AGREEMENT

This Amendment of Stock Option Agreement is entered
into by and between Weili Dai (the “Optionee”) and Marvell Technology Group
Ltd., a Bermuda corporation (the “Company”), effective as set forth below.

Recitals

WHEREAS, the Company previously issued to the Optionee
the following options (collectively, the “Options”) to acquire shares of common
stock of the Company under the Company’s Amended and Restated 1995 Stock Option
Plan (all references to shares and per share prices in this Amendment of Stock
Option Agreement are as adjusted for subsequent stock splits):

1.               an option pursuant
to a stock option agreement originally dated effective June 6, 2002,

2.               an option pursuant
to a stock option agreement originally dated effective December 26, 2003,

3.               an option pursuant
to a stock option agreement originally dated effective March 10, 2006,

4.               an option pursuant
to a stock option agreement originally dated effective May 25, 2006,
(collectively, the “Agreements”); and

WHEREAS, in connection with the Optionee’s termination
of service as an officer of the Company effective as of May 6, 2007 the parties
desire to amend the Options and Agreements.

Agreement

NOW, THEREFORE, the parties hereto, intending to be
legally bound, hereby agree as follows:

A.            The
terms of the Options and Agreements are hereby amended to reflect that the
Optionee’s service to the Company and its affiliates whether as an employee,
consultant, director or otherwise will be deemed to have terminated effective
as of May 6, 2007 (the “Termination Date”) for all purposes of the Options,
including but not limited to cessation of vesting of the Options, termination
of Options which have not vested as of the Termination Date and commencement of
the period in which the Optionee may exercise vested Options after a
termination of service (as such period is modified pursuant to this Amendment
of Stock Option Agreement), notwithstanding that the Optionee may continue in
employment or other service with the Company and its affiliates following the
Termination Date.

B.            The
terms of the Options and Agreements are hereby amended to reflect that the period in which the Optionee may exercise
vested Options after the Termination Date is extended to the 30th day after the Optionee receives
written notice from the Company that Optionee is permitted to exercise the
Options under applicable securities laws (if later than the period in which the
Optionee may exercise the vested Options after a termination of service as of the Termination Date pursuant to the
original terms of the Optionee’s Agreements); provided, however, that
the exercise period for any such Option shall not be extended beyond the original
expiration date of such Option as set forth in the Optionee’s Agreements.

C.            The
terms of the Agreements not specifically amended hereby (subject to any prior
or contemporaneous reformation of such Agreements) remain in full force and
effect.

D.            This
Amendment of Stock Option Agreement shall be governed by the laws of the State
of California.

E.             The
Optionee has had an opportunity to consult with the Optionee’s personal tax,
legal and investment advisors with regard to this Amendment of Stock Option Agreement,
and is not relying on the Company or its agents for such advice.  The Optionee agrees that the Company shall
not be liable for any costs, taxes, loss or damage that the Optionee may incur
by entering into the Agreements or this Amendment of Stock Option Agreement; it
being understood that the Optionee will not pursue a claim, whether by way of
indemnification or otherwise (i) with respect to such costs, taxes, loss or
damage or (ii) with respect to costs incurred in connection with the
negotiation and preparation of this Amendment of Stock Option Agreement;
provided, however, that nothing herein shall otherwise affect any rights of the
Optionee to indemnification pursuant to the Company’s bye-laws or any other
agreements or instruments of or with the Company or any of its subsidiaries.

The parties hereto have duly executed this Amendment
of Stock Option Agreement effective as of the latest date set forth below.

	
  MARVELL TECHNOLOGY GROUP
  LTD.

  
	
   

  
	
  By:

  	
  /s/ Paul R. Gray

  	
   

  
	
   

  
	
  Name:

  	
  Paul R. Gray

  	
   

  
	
   

  
	
  Title:

  	
  On behalf of
  Implementation Committee

  	
   

  
	
   

  
	
  Date:

  	
  May 6, 2007

  	
   

  
	
   

  
	
   

  	
  /s/ Weili Dai

  	
   

  
	
   

  	
  Signature of
  Optionee

  
	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
  Weili Dai

  
	
   

  	
   

  
	
   

  	
  Date:

  	
  5/6/2007

  	
   

  
											

 

 2EXHIBIT
10.60

AMENDMENT FOUR

TO THE MANUFACTURING AGREEMENT

BY AND BETWEEN VIVUS AND CHINOIN

This Amendment Four (“Amendment Four”), effective as
of December 31, 2006 (“Amendment Date”), by and between VIVUS, Inc.,
having a principal place of business at 1172 Castro Street, Mountain View, CA
94040 United States of America (“VIVUS”), and CHINOIN Pharmaceutical and
Chemical Works Private Co. Ltd., having a principal place of business at
H-1045, Budapest, To u. 1-5 Hungary (“CHINOIN”) (VIVUS and CHINOIN collectively,
the “Parties”), amends (i) that certain Manufacturing Agreement by and
between the Parties dated December 20, 1995 (the “Agreement”) and
(ii) Amendment One to the Agreement dated December 11, 1997 (“Amendment
One”) and (iii) Amendment Two to the Agreement dated December 18,
1998 (“Amendment Two”) and (iv) Amendment Three to the Agreement dated
November 21, 2002 (“Amendment Three”)

The Parties desire to amend the Agreement, the
Amendment One, the Amendment Two and Amendment Three as set forth herein below;

NOW, THEREFORE, the Parties agree as follows:

1.             AMENDMENT.  This Amendment Four hereby amends the
Agreement to incorporate the terms and conditions set forth in this Amendment
Four.  The relationship of the Parties
shall continue to be governed by the terms and conditions of the Agreement, the
Amendments One, Two and Three, as amended herein; and in the event that there
is any conflict between the terms and conditions of the Agreement or Amendment
One or Two or Three and this Amendment Four, the terms and conditions of this
Amendment Four shall control.  As used in
this Amendment Four, all capitalized terms shall have the meanings defined for
such terms in this Amendment Four or, if not defined in this Amendment Four,
the meanings defined in the Agreement.

2.             MODIFICATION TO THE
AGREEMENT.

2.1           The Parties hereby
acknowledge the change of the full name of CHINOIN from CHINOIN Pharmaceutical
and Chemical Works Co. Ltd. to CHINOIN Pharmaceutical and Chemical Works
Private Co. Ltd.

2.2           The Parties hereby agree
to prolong the validity of the Agreement for calendar year 2011, being
considered Agreement Year fifth teen.

2.3           The Parties agree
that VIVUS shall not be required to purchase from CHINOIN any amount of the
Product in the remainder of the tenth Agreement Year (calendar year 2006), and
also in Agreement Years twelve (2008) and fourteen (2010).  VIVUS shall have only the

following firm commitments to purchase the Product
from CHINOIN during the validity of the Agreement as extended according to
Section 2.2 of this Amendment Four:

2.3.1        From the eleventh
Agreement Year onward, and for quantities of the Product VIVUS orders that are
in excess of its existing minimum contractual purchase obligations, VIVUS
agrees to place not less than [**] of its orders for the Product (based on
mass) from CHINOIN.  In no event will
CHINOIN be obligated to supply more than [**] of Product annually.

2.3.2        Section 2.12 of
the Agreement is hereby amended in its entirety to read as follows:

2.12        Minimum Quantities

2.12.1     VIVUS agrees that the quantity of Product
purchased from CHINOIN shall in no event fall below the minimum quantity of [**] in Agreement Years eleven (2007), thirteen (2009), and fifth teen
(2011).  This undertaking is not subject
to any waiver due to decrease of the consumption of the Product.

2.4           Section 2.7 of
the Agreement as modified by Amendment One and Amendment Three is hereby
amended in its entirety to read as follows:

2.7          Price.  The price to be paid by VIVUS
per [**] of the Product ordered by
VIVUS shall be based upon the quantities of the Product ordered by VIVUS for
delivery during the particular Agreement Year, as follows:

2.7.2       Quantity Ordered for Delivery During
the eleventh, thirteenth and fifth teen Agreement Years:

	
  

  	
   

  	
  U.S.
  $/[**]

  
	
   

  	
   

  	
   

  
	
  First
  [**] “Minimum Annual Quantity”

  	
   

  	
  $[**]

  
	
   

  	
   

  	
   

  
	
  Quantities
  in excess of [**], up to [**]

  	
   

  	
  $[**]

  
	
   

  	
   

  	
   

  
	
  Quantities
  in excess of [**], up to [**]

  	
   

  	
  $[**]

  
	
   

  	
   

  	
   

  
	
  Quantities
  in excess of [**], up to [**]

  	
   

  	
  $[**]

  
	
   

  	
   

  	
   

  
	
  Quantities
  in excess of [**], up to [**]

  	
   

  	
  $[**]

  
	
   

  	
   

  	
   

  
	
  Quantities
  in excess of [**], if any

  	
   

  	
  $[**]

  

 

It is understood that the
foregoing prices are based upon the total cumulative quantities ordered by
VIVUS for delivery during the particular Agreement Year, and not only on the
size of the particular order or delivery. 
It is also understood that the prices are for the incremental
quantities.

[**] — Confidential
treatment has been requested for the bracketed portions. The confidential
redacted portion has been omitted and filed separately with the Securities and
Exchange Commission.

 2
 

3.             ENTIRE AGREEMENT.  The Agreement and any Exhibits and Addenda
thereto together with this Amendment Four and Amendment One, Amendment Two and
Amendment Three constitute the entire agreement between the Parties with
respect to the subject matter thereof and supersede all prior and
contemporaneous communications, representations, agreements or understandings,
either written or oral, between the Parties.

IN
WITNESS WHEREOF, the parties hereto have executed this Amendment Four.

 

	
  VIVUS, INC.

  	
   

  	
  CHINOIN PHARMACEUTICAL AND

  CHEMICAL WORKS PRIVATE CO., LTD.

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  By:

  	
   

  	
  /s/ Leland F. Wilson

  	
   

  	
  By:

  	
   

  	
  /s/ Frédéric OLLIER

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  Name:

  	
   

  	
  Leland F. Wilson

  	
   

  	
  Name:

  	
   

  	
  Frédéric OLLIER

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  Title:

  	
   

  	
  President & CEO

  	
   

  	
  Title:

  	
   

  	
  Managing Director

  

 

 

	
  

  	
   

  	
   

  	
   

  	
  By:

  	
   

  	
  /s/ Michel DARGENTOLLE

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
  Name:

  	
   

  	
  Michel DARGENTOLLE

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
  Title:

  	
   

  	
  VP Administration & Finance

  

 

 3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00122-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00122-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00122-of-00352.parquet"}]]